Internal Competition Completed
Principal Investigators Selected
- Maximo Oscar Brito is authorized to submit, Department of Infectious Diseases
EXPEDITED REVIEW - DUE MONDAY JUNE 26TH AT NOON
This multi-pronged initiative will support up to two (2) recipients to improve the prevention, care, treatment, and cure of hepatitis C (HCV) in areas affected by HIV/HCV coinfection among low-income, underinsured, or uninsured racial and ethnic minority populations. Components of the initiative will include: • Expansion of HCV prevention (including education), testing, care (including preventive health care), and treatment capacity among RWHAP-funded clinics, HRSA and Medicare-certified Federally Qualified Health Centers (FQHCs), 1 and SAMHSA-funded community-based substance use disorder (SUD) and behavioral health treatment providers that predominantly serve people of color living with both HIV and HCV; • Improved coordination of linkage to and retention in care and treatment for people who are co-infected with HIV/HCV; • Improved coordination with SAMHSA-funded SUD treatment providers to expand the delivery of behavioral health and substance use treatment support to achieve treatment completion and to prevent HCV infection and re-infection; and • Enhancement of health department surveillance systems to increase their capacity to monitor acute and chronic coinfections of HIV and HCV in areas affected by HIV/HCV coinfection among low-income, underinsured, or uninsured racial and ethnic minority populations, and to enable an HCV Data to Care capacity.
Recipients will be expected to partner with and provide annual subawards to clinical sites seeking to improve their capacity to treat HIV/HCV coinfection among low-income, underinsured, or uninsured racial/ethnic minority populations. Applicants should propose how they will work with subrecipients to increase capacity in the following areas: • Provision of HIV/HCV coinfection care and treatment according to the HHS guidelines; • Provision of HIV/HCV medication adherence support; • Performance of necessary lab testing, referrals for liver biopsy and other staging procedures; and • Provision of prevention education about HCV infection and re-infection.
You should propose how you will accomplish the following activities: • Formation of partnerships (which may include providing subawards) with local SUD and mental health treatment provider(s) to build their capacity to provide integrated care and to enable bidirectional client referrals for appropriate HIV/HCV and SUD treatment; • Linkage of clients of clinical sites who screen positive for SUDs into SUD treatment, either at the clinical site or at the partnering agency; • Linkage of clients in SUD and mental health treatment who test or are identified as living with HIV and HCV and who are out of care to the clinical site for treatment; • Provision of interventions by clinical sites working with SUD and mental health treatment providers to clients living with HIV and HCV with SUDs to prevent overdose and re-infection (including referrals to syringe services programs, or SSPs); and • Provision of referrals to community education programs, including those which address the benefits of access to medication-assisted treatment (MAT) and SSPs.
BUDGET: Approximately $5,000,000 is expected to be available annually to fund up to two (2) recipients. You may apply for a ceiling amount of up to $2,500,000 total cost (includes both direct and indirect/facilities and administrative costs) per year.
University is limited to one proposal.
|UIC Letter of Intent||
June 26, 2017
|UIC Internal Competition||
|Sponsor Letter of Intent||
July 28, 2017
Letter of Intent
EXPEDITED REVIEW - IN ADDITION TO THE ONLINE LOI PLEASE INCLUDE AN OVERVIEW OF THE FOLLOWING (ONE PAGE LIMIT) DUE MONDAY JUNE 26TH AT NOON
1. Program narrative (goals and objectives)
2. Extent to which the proposed project implementation plan addresses any gaps described in the needs assessment of the program narrative.
3. Extent of the current capacity to collect and report to the evaluation team on a timely, regular basis, the required HCV care outcomes and additional measures
4. Resources and Capabilities
5. Proposed Partnerships
Please contact Natalia Glubisz at RDS@uic.edu or 312-996-8348 with any questions.
If an authorized principal investigator is not listed above, please consider the limited competition still open. Contact RDS@uic.edu for further information.